282 related articles for article (PubMed ID: 29464940)
1. Multiplatform plasma fingerprinting in cancer cachexia: a pilot observational and translational study.
Cala MP; Agulló-Ortuño MT; Prieto-García E; González-Riano C; Parrilla-Rubio L; Barbas C; Díaz-García CV; García A; Pernaut C; Adeva J; Riesco MC; Rupérez FJ; Lopez-Martin JA
J Cachexia Sarcopenia Muscle; 2018 Apr; 9(2):348-357. PubMed ID: 29464940
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers related to fatty acid oxidative capacity are predictive for continued weight loss in cachectic cancer patients.
Catanese S; Beuchel CF; Sawall T; Lordick F; Brauer R; Scholz M; Ceglarek U; Hacker UT
J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):2101-2110. PubMed ID: 34636159
[TBL] [Abstract][Full Text] [Related]
3. Targeted metabolomics identifies perturbations in amino acid metabolism that sub-classify patients with COPD.
Ubhi BK; Cheng KK; Dong J; Janowitz T; Jodrell D; Tal-Singer R; MacNee W; Lomas DA; Riley JH; Griffin JL; Connor SC
Mol Biosyst; 2012 Oct; 8(12):3125-33. PubMed ID: 23051772
[TBL] [Abstract][Full Text] [Related]
4. Serum amino acid metabolic profiles of ankylosing spondylitis by targeted metabolomics analysis.
Zhou Y; Zhang X; Chen R; Han S; Liu Y; Liu X; Gao M; Yang C; Lu D; Sun B; Chen H
Clin Rheumatol; 2020 Aug; 39(8):2325-2336. PubMed ID: 32130577
[TBL] [Abstract][Full Text] [Related]
5. Derangements of amino acids in cachectic skeletal muscle are caused by mitochondrial dysfunction.
Kunzke T; Buck A; Prade VM; Feuchtinger A; Prokopchuk O; Martignoni ME; Heisz S; Hauner H; Janssen KP; Walch A; Aichler M
J Cachexia Sarcopenia Muscle; 2020 Feb; 11(1):226-240. PubMed ID: 31965747
[TBL] [Abstract][Full Text] [Related]
6. Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/ gas chromatography mass spectrometry platform.
Callejón-Leblic B; García-Barrera T; Grávalos-Guzmán J; Pereira-Vega A; Gómez-Ariza JL
J Proteomics; 2016 Aug; 145():197-206. PubMed ID: 27255828
[TBL] [Abstract][Full Text] [Related]
7. Urine metabolic fingerprinting using LC-MS and GC-MS reveals metabolite changes in prostate cancer: A pilot study.
Struck-Lewicka W; Kordalewska M; Bujak R; Yumba Mpanga A; Markuszewski M; Jacyna J; Matuszewski M; Kaliszan R; Markuszewski MJ
J Pharm Biomed Anal; 2015; 111():351-61. PubMed ID: 25684700
[TBL] [Abstract][Full Text] [Related]
8. Serum Untargeted Metabolomics Reveal Potential Biomarkers of Progression of Diabetic Retinopathy in Asians.
Wang Z; Tang J; Jin E; Zhong Y; Zhang L; Han X; Liu J; Cheng Y; Hou J; Shi X; Qi H; Qian T; Yuan L; Hou X; Yin H; Liang J; Zhao M; Huang L; Qu J
Front Mol Biosci; 2022; 9():871291. PubMed ID: 35755823
[No Abstract] [Full Text] [Related]
9. Study of the metabolomics characteristics of patients with metabolic syndrome based on liquid chromatography quadrupole time-of-flight mass spectrometry.
Wu N; Wang W; Yi M; Cheng S; Wang D
Ann Endocrinol (Paris); 2018 Feb; 79(1):37-44. PubMed ID: 29246383
[TBL] [Abstract][Full Text] [Related]
10. Multi-platform metabonomics unravel amino acids as markers of HIV/combination antiretroviral therapy-induced oxidative stress.
Sitole LJ; Tugizimana F; Meyer D
J Pharm Biomed Anal; 2019 Nov; 176():112796. PubMed ID: 31398507
[TBL] [Abstract][Full Text] [Related]
11. Multiplatform Urinary Metabolomics Profiling to Discriminate Cachectic from Non-Cachectic Colorectal Cancer Patients: Pilot Results from the ColoCare Study.
Ose J; Gigic B; Lin T; Liesenfeld DB; Böhm J; Nattenmüller J; Scherer D; Zielske L; Schrotz-King P; Habermann N; Ochs-Balcom HM; Peoples AR; Hardikar S; Li CI; Shibata D; Figueiredo J; Toriola AT; Siegel EM; Schmit S; Schneider M; Ulrich A; Kauczor HU; Ulrich CM
Metabolites; 2019 Sep; 9(9):. PubMed ID: 31500101
[TBL] [Abstract][Full Text] [Related]
12. A Pilot Study for Investigation of Plasma Amino Acid Profile in Neurofibromatosis Type 1 Patients.
Oz O; Koyuncu I; Gonel A
Comb Chem High Throughput Screen; 2022; 25(1):114-122. PubMed ID: 33280590
[TBL] [Abstract][Full Text] [Related]
13. Multiplatform plasma metabolic and lipid fingerprinting of breast cancer: A pilot control-case study in Colombian Hispanic women.
Cala MP; Aldana J; Medina J; Sánchez J; Guio J; Wist J; Meesters RJW
PLoS One; 2018; 13(2):e0190958. PubMed ID: 29438405
[TBL] [Abstract][Full Text] [Related]
14. Serum and urine metabolomics study reveals a distinct diagnostic model for cancer cachexia.
Yang QJ; Zhao JR; Hao J; Li B; Huo Y; Han YL; Wan LL; Li J; Huang J; Lu J; Yang GJ; Guo C
J Cachexia Sarcopenia Muscle; 2018 Feb; 9(1):71-85. PubMed ID: 29152916
[TBL] [Abstract][Full Text] [Related]
15. Multi Platforms Strategies and Metabolomics Approaches for the Investigation of Comprehensive Metabolite Profile in Dogs with
Rubić I; Burchmore R; Weidt S; Regnault C; Kuleš J; Barić Rafaj R; Mašek T; Horvatić A; Crnogaj M; Eckersall PD; Novak P; Mrljak V
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163517
[TBL] [Abstract][Full Text] [Related]
16. Multi-compartment metabolomics and metagenomics reveal major hepatic and intestinal disturbances in cancer cachectic mice.
Pötgens SA; Thibaut MM; Joudiou N; Sboarina M; Neyrinck AM; Cani PD; Claus SP; Delzenne NM; Bindels LB
J Cachexia Sarcopenia Muscle; 2021 Apr; 12(2):456-475. PubMed ID: 33599103
[TBL] [Abstract][Full Text] [Related]
17. Urinary metabolomics study the mechanism of Taohong Siwu Decoction intervention in acute blood stasis model rats based on liquid chromatography coupled to quadrupole time-of-flight mass spectrometry.
Zhang X; Li P; Hua Y; Ji P; Yao W; Ma Q; Yuan Z; Wen Y; Yang C; Wei Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Feb; 1074-1075():51-60. PubMed ID: 29331744
[TBL] [Abstract][Full Text] [Related]
18. Metabolomic study of serum in patients with invasive ductal breast carcinoma with LC-MS/MS approach.
Amiri-Dashatan N; Yekta RF; Koushki M; Arefi Oskouie A; Esfahani H; Taheri S; Kazemian E
Int J Biol Markers; 2022 Dec; 37(4):349-359. PubMed ID: 36168301
[TBL] [Abstract][Full Text] [Related]
19. Integrated metabolomic profiling of hepatocellular carcinoma in hepatitis C cirrhosis through GC/MS and UPLC/MS-MS.
Fitian AI; Nelson DR; Liu C; Xu Y; Ararat M; Cabrera R
Liver Int; 2014 Oct; 34(9):1428-44. PubMed ID: 24661807
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
